摘要
背景:日常生活工具活动(IADL)是一种复杂的活动,涉及多种认知过程,容易受到认知的早期影响。损伤。以线人为基础的问卷是评估痴呆患者IADL表现的最常用工具,但在早期损伤阶段必须加以调整。 目的:探讨认知功能减退(无认知下降-主观认知功能减退-轻度认知功能损害-轻度痴呆-中度认知功能衰退)在认知功能障碍(IADL)上的差异。痴呆症)使用西班牙版的阿姆斯特丹IADL问卷(A-IADL-Q)。 方法:包括500名志愿者:88名无认知减退症状的参与者,109名主观认知投诉的参与者,114名轻度认知功能减退的参与者。轻度痴呆81例,中度痴呆108例。评估IADL的方法是A-IADL-Q,这是一份计算机化的自适应问卷,计算的是核心根据每个参与者的具体反应模式。资料采用ANOVAS和回归分析。用多项Logistic回归分析评价ca。A-IADL-Q的频域区分诊断组. 结果:无认知下降和主观认知功能下降的受试者A-IADL-Q得分高于MCI组,MCI组高于MCI组。痴呆症患者。A-IADL-Q对非认知障碍和痴呆有很好的鉴别能力,对非认知功能障碍和MCI的区分程度显著但低。 结论:α-IADL-Q能在不同痴呆谱组间鉴别IADL的功能.
关键词: 日常生活工具活动、阿姆斯特丹IADL问卷、日常活动、主观认知能力下降、轻度认知障碍、痴呆、多项Logistic回归分析。
Current Alzheimer Research
Title:Assessing Everyday Activities Across the Dementia Spectrum with the Amsterdam IADL Questionnaire
Volume: 15 Issue: 13
关键词: 日常生活工具活动、阿姆斯特丹IADL问卷、日常活动、主观认知能力下降、轻度认知障碍、痴呆、多项Logistic回归分析。
摘要: Background: Instrumental activities of daily living (IADL) are complex activities which involve multiple cognitive processes, and which are expected to be susceptible to the early effects of cognitive impairment. Informant-based questionnaires are the most common tools used to assess IADL performance in dementia, but must be adjusted for use in early stages of impairment.
Objective: To investigate the differences in IADL on the continuum of cognitive decline (i.e. no cognitive decline - subjective cognitive decline - mild cognitive impairment- mild dementia - moderate dementia) using the Spanish version of the Amsterdam IADL Questionnaire (A-IADL-Q).
Methods: A total of 500 volunteer participants were included: 88 participants with no signs of cognitive decline, 109 participants with subjective cognitive complaints, 114 participants with mild cognitive impairment (MCI), 81 participants with mild dementia and 108 participants with moderate dementia. IADL was assessed with the A-IADL-Q, a computerized and adaptive questionnaire that calculates scores according to the specific pattern of responses of each participant. The data were examined by ANOVAs and regression analysis. Multinomial logistic regression analysis was used to evaluate the capacity of the A-IADL-Q to distinguish between diagnostic groups.
Results: Participants with no cognitive decline and those with subjective cognitive decline obtained higher A-IADL-Q scores than MCI participants, and participants with MCI obtained higher scores than patients with dementia. The A-IADL-Q showed excellent discrimination between non-cognitive impairment and dementia, and significant but low discrimination between non-cognitive impairment and MCI.
Conclusion: A-IADL-Q can discriminate IADL functioning between groups across the dementia spectrum.
Export Options
About this article
Cite this article as:
Assessing Everyday Activities Across the Dementia Spectrum with the Amsterdam IADL Questionnaire, Current Alzheimer Research 2018; 15 (13) . https://dx.doi.org/10.2174/1567205015666180925113411
DOI https://dx.doi.org/10.2174/1567205015666180925113411 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic:Fluorine-Containing Drugs as PET Diagnostics (F-18 Labeled Tracers)]
Current Topics in Medicinal Chemistry Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Involvement of Coagulation and Hemostasis in Inflammatory Bowel Diseases
Current Vascular Pharmacology Motor Neuron Disease and Acquired Axonal Neuropathy Association in HIV Infection: Case Report and Update
Current HIV Research Subject Index to Volume 11
Protein & Peptide Letters Sleep, Depression and Insomnia – A Vicious Circle?
Current Psychiatry Reviews Editorial [Hot Topic: Advances in Alzheimer Therapy: Development of Innovative New Strategies (Guest Editors: Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri)]
Current Alzheimer Research Rapid HILIC Method for Assay and Dissolution Analysis of Rivastigmine Hydrogen Tartrate from Hydrophilic Matrix
Current Pharmaceutical Analysis Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research Developments in HIV Neuropathogenesis
Current Pharmaceutical Design Lentiviral Vector-Based Models of Amyloid Pathology: From Cells to Animals
Current Alzheimer Research Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects
Current Stem Cell Research & Therapy Metacognition and Social Functioning in Schizophrenia: Evidence, Mechanisms of Influence and Treatment Implications
Current Psychiatry Reviews Preface [Hot Topic: Current Trends in the Development of Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents (Executive Editors: P. Camps and D. Munoz-Torrero)]
Current Pharmaceutical Design Current State of Saliva Biomarkers for Aging and Alzheimer’s Disease
Current Alzheimer Research Characterization of the Effect of a Novel γ-secretase Modulator on Aβ: A Clinically Translatable Model
Current Pharmaceutical Design Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer’s Disease: An LC-MS/MS-based Metabolomics Analysis
Current Alzheimer Research Subject Index to Volume 4
Current Medicinal Chemistry - Central Nervous System Agents Investigation on Risk Factor of Vascular Thrombotic Diseases in Patients with Obstructive Sleep Apnea Hypopnea Syndrome
Vascular Disease Prevention (Discontinued)